Global Patent Index - EP 0971697 A2

EP 0971697 A2 2000-01-19 - MEDICAMENT HAVING SCLEROSING ACTIVITY

Title (en)

MEDICAMENT HAVING SCLEROSING ACTIVITY

Title (de)

ARZNEIMITTEL MIT VERÖDUNGSWIRKUNG

Title (fr)

MEDICAMENT EXER ANT UN EFFET SCLEROSANT

Publication

EP 0971697 A2 (EN)

Application

EP 98920482 A

Priority

  • EP 9801699 W
  • IT MI970700 A

Abstract (en)

[origin: WO9842312A2] This invention relates to the use of a solution of a soluble, pharmaceutically acceptable salt of salicylic acid, said solution having a pH between 7.0 (+/-1) and 9.0 (+/-1), as active ingredient for the preparation of a medicament having sclerosing activity useful for the treatment of varixes.

IPC 1-7 (main, further and additional classification)

A61K 9/08

IPC 8 full level (invention and additional information)

A61K 9/00 (2006.01); A61K 31/60 (2006.01); A61K 47/02 (2006.01)

CPC (invention and additional information)

A61K 31/60 (2013.01); A61K 9/0019 (2013.01); A61K 47/02 (2013.01)

Citation (search report)

See references of WO 9842312A3

Designated contracting state (EPC)

DE ES FR GB IT

EPO simple patent family

WO 9842312 A2 19981001; WO 9842312 A3 19981105; EP 0971697 A2 20000119; IT 1290439 B1 19981203; IT MI970700 A1 19980925

INPADOC legal status


2005-03-09 [18D] DEEMED TO BE WITHDRAWN

- Ref Legal Event Code: 18D

- Effective date: 20040824

2001-07-18 [17Q] FIRST EXAMINATION REPORT

- Ref Legal Event Code: 17Q

- Effective date: 20010605

2000-03-22 [RIC1] CLASSIFICATION (CORRECTION)

- Ref Legal Event Code: RIC1

- Free Format Text: 7A 61K 31/60 A

2000-01-19 [17P] REQUEST FOR EXAMINATION FILED

- Ref Legal Event Code: 17P

- Effective date: 19990921

2000-01-19 [AK] DESIGNATED CONTRACTING STATES:

- Ref Legal Event Code: AK

- Designated State(s): DE ES FR GB IT